ATRX immunostaining predicts IDH and H3F3A status in gliomas.
Ebrahimi A, Skardelly M, Bonzheim I, Ott I, Mühleisen H, Eckert F, Tabatabai G, Schittenhelm J.
Ebrahimi A, et al. Among authors: eckert f.
Acta Neuropathol Commun. 2016 Jun 16;4(1):60. doi: 10.1186/s40478-016-0331-6.
Acta Neuropathol Commun. 2016.
PMID: 27311324
Free PMC article.